Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by rex50on Oct 18, 2014 11:53am

215 Views

Post# 23040489

RE:RE:RE:Anything interesting on the conference call?

Increased market share will happen surely but slowly over coming quarters as there are only a dozen salesperson for whole USA. Our management is very conservative and prudent fortunately. So any further increase in revenue will mostly go to cash flow and net profit. Another observation is cost of goods incresed just 50k while revenue went up by 1350k. Give them another 6 -12 months and SP will be multiples of current SP imo.

Bullboard Posts

How a junior advances one of the largest undeveloped diamond projects